LMAT
LEMAITRE VASCULAR INCCompany Information
- Company Name
- LEMAITRE VASCULAR INC
- CIK
- CIK0001158895
- Category
- Large accelerated filer
- Ticker: Exchange
- LMAT: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- LMAT
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- 2026-05-08
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 240,171.68
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 21,659,697
- Shares outstanding
- 22,858,000
- Ownership
- 94.76%
Earnings Market Reaction
- Filing date
- 2026-08-05
- Price on filing date
- —
- 1-month reaction
- 2.14%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 27 | 27 | 28 | 25 | 27 | 25 | 26 | 21 | 22 | 27 | 24 | 18 | ||||||
| Available For Sale Securities Debt Securities Current | 350 | 340 | 331 | 318 | 292 | 277 | 274 | 103 | 91 | 82 | 81 | 79 | ||||||
| Accounts Receivable Net Current | 36 | 36 | 34 | 32 | 37 | 35 | 30 | 32 | 31 | 30 | 25 | 24 | ||||||
| Prepaid Expense And Other Assets Current | 6 | 4 | 5 | 6 | 6 | 5 | 7 | 6 | 5 | 4 | 6 | 5 | ||||||
| Assets Current | 488 | 478 | 468 | 452 | 430 | 408 | 402 | 227 | 213 | 203 | 195 | 182 | ||||||
| Property Plant And Equipment Net | 30 | 29 | 27 | 26 | 25 | 25 | 25 | 24 | 23 | 22 | 22 | 21 | ||||||
| Operating Lease Right Of Use Asset | 20 | 20 | 16 | 16 | 17 | 16 | 17 | 17 | 17 | 18 | 18 | 16 | ||||||
| Goodwill | 66 | 66 | 66 | 66 | 66 | 66 | 66 | 66 | 66 | 66 | 66 | 66 | ||||||
| Intangible Assets Net Excluding Goodwill | 31 | 32 | 33 | 32 | 33 | 34 | 36 | 37 | 39 | 40 | 42 | 43 | ||||||
| Deferred Income Tax Assets Net | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | ||||||
| Other Assets Noncurrent | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 4 | 4 | 4 | 3 | ||||||
| Assets | 641 | 630 | 616 | 598 | 578 | 556 | 552 | 377 | 363 | 354 | 347 | 334 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 3 | 4 | 4 | 3 | 5 | 2 | 2 | 2 | 2 | 3 | 4 | 4 | ||||||
| Accrued Liabilities Current | 23 | 25 | 29 | 27 | 23 | 20 | 25 | 23 | 21 | 21 | 24 | 22 | ||||||
| Operating Lease Liability Current | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 3 | ||||||
| Liabilities Current | 30 | 33 | 36 | 33 | 31 | 25 | 31 | 29 | 25 | 27 | 30 | 29 | ||||||
| Convertible Debt Noncurrent | 169 | 169 | 169 | 168 | 168 | 168 | 168 | - | - | - | 0 | - | ||||||
| Operating Lease Liability Noncurrent | 18 | 18 | 14 | 14 | 15 | 15 | 15 | 16 | 16 | 16 | 17 | 14 | ||||||
| Deferred Income Tax Liabilities Net | 2 | 2 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Liabilities Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | ||||||
| Liabilities | 220 | 223 | 222 | 219 | 215 | 208 | 215 | 46 | 44 | 45 | 49 | 45 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 236 | 233 | 228 | 224 | 221 | 217 | 214 | 211 | 209 | 206 | 201 | 198 | ||||||
| Retained Earnings Accumulated Deficit | 206 | 195 | 185 | 174 | 161 | 152 | 145 | 138 | 130 | 122 | 115 | 110 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -4 | -4 | -2 | -3 | -3 | -5 | -6 | -3 | -5 | -6 | -5 | -7 | ||||||
| Treasury Stock Common Value | -18 | -18 | -17 | -16 | -16 | -16 | -16 | -14 | -14 | -14 | - | -13 | ||||||
| Stockholders Equity | 420 | 407 | 394 | 379 | 363 | 348 | 337 | 331 | 320 | 309 | 298 | 289 | ||||||
| Treasury Stock Value | - | - | - | - | - | - | -16 | - | - | - | -14 | - | ||||||
| Liabilities And Stockholders Equity | 641 | 630 | 616 | 598 | 578 | 556 | 552 | 377 | 363 | 354 | 347 | 334 | ||||||
| Allowance For Doubtful Accounts Receivable Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Preferred Stock Shares Authorized | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | - | - | - | 0 | - | - | - | - | - | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Common Stock Shares Authorized | 37 | 37 | 37 | 37 | 37 | 37 | 37 | 37 | 37 | 37 | 37 | 37 | ||||||
| Common Stock Shares Issued | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | ||||||
| Shares Outstanding | 23 | 23 | 23 | - | - | - | 23 | - | - | - | - | - | ||||||
| Treasury Stock Common Shares | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialLEMAITRE VASCULAR INC (LMAT) — SEC Financial Statements & Analysis
LEMAITRE VASCULAR INC (LMAT) is a surgical & medical instruments & apparatus company. LEMAITRE VASCULAR INC trades on Nasdaq as: LMAT. LEMAITRE VASCULAR INC (LMAT)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05. Based on that filing, LEMAITRE VASCULAR INC carries a market cap of $2.19B, a P/E ratio of 33.30x, a P/B ratio of 5.20x, a P/S ratio of 8.33x, an enterprise value of $2.33B, and an EV/EBITDA multiple of 26.52x. On profitability, it posts a gross margin of 72.90%, an operating margin of 29.46%, a net margin of 25.02%, a Return on Equity (ROE) of 16.77%, a Return on Assets (ROA) of 10.78%, and a Return on Invested Capital (ROIC) of 11.13%. Per share, it reports EPS of $2.87, diluted EPS of $2.68, free cash flow per share of $3.23, and a dividend per share of $0.90. Over the trailing year, it posted revenue growth of 11.85% year-over-year, net income growth of 39.39% year-over-year, and EPS growth of 37.90% year-over-year. On the balance sheet, it maintains a current ratio of 16.31x, a quick ratio of 16.12x, working capital of $458.36M, a debt-to-equity ratio of 0.52x, a debt ratio of 0.34, an interest coverage ratio of 14.88x, free cash flow of $73.83M (TTM), and net debt of $142.47M. Figures sourced from SEC EDGAR.
- Market Cap
- $2.19B
- P/E TTM
- 33.30x
- EPS TTM
- $2.87
- P/B TTM
- 5.20x
- ROE TTM
- 16.77%
- ROA TTM
- 10.78%
- Debt To Equity
- 0.52x
- Free Cash Flow TTM
- $73.83M
- Net Revenue TTM Growth 1Y
- 11.85%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is LEMAITRE VASCULAR INC in?
LEMAITRE VASCULAR INC (LMAT) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does LMAT trade on?
LEMAITRE VASCULAR INC (LMAT) trades on the Nasdaq.
When was LEMAITRE VASCULAR INC (LMAT)'s most recent SEC filing?
LEMAITRE VASCULAR INC (LMAT)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05.
What is LMAT's market cap?
LEMAITRE VASCULAR INC (LMAT) has a market capitalization of $2.19B as of 2026-06-30.
What is LMAT's P/E ratio?
LEMAITRE VASCULAR INC (LMAT)'s trailing twelve month P/E ratio is 33.30x as of 2026-06-30.
What is LMAT's EPS (earnings per share)?
LEMAITRE VASCULAR INC (LMAT)'s trailing twelve month EPS is $2.87 as of 2026-06-30.
What is LMAT's ROE (return on equity)?
LEMAITRE VASCULAR INC (LMAT)'s trailing twelve month Return on Equity (ROE) is 16.77% as of 2026-06-30.
What is LMAT's ROA (return on assets)?
LEMAITRE VASCULAR INC (LMAT)'s trailing twelve month Return on Assets (ROA) is 10.78% as of 2026-06-30.
What is LMAT's ROIC (return on invested capital)?
LEMAITRE VASCULAR INC (LMAT)'s trailing twelve month Return on Invested Capital (ROIC) is 11.13% as of 2026-06-30.
What is LMAT's EV/EBITDA?
LEMAITRE VASCULAR INC (LMAT)'s trailing twelve month EV/EBITDA is 26.52x as of 2026-06-30.